Quinnipiac University School of Law recently released its most recent volume of the Health Law Journal, which included Follow-on Biologics Protecting Consumers Through State Pharmacy Law in Light of FDA Actions, authored by Aimed Alliance’s directory of public policy, Stacey L. Worthy. The article argues that recent FDA informal rules and actions violate the Public Health Safety Act, trade secret law, and Fifth Amendment taking jurisprudence. It also finds that, in light of the level of deference that federal agencies receive, states must step in to protect patients. States must develop new statutory protections for patients that provide physicians, and not pharmacists, with the authority to decide, in conjunction with the patient, whether the FOB can be substituted for a particular patient. The benefits of such legislation outweigh the costs. You can read the article in its entirety here: Follow On Biologics
Last Updated on April 22, 2020 by Aimed Alliance
